This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

Emile Voest group

Emile Voest

Emile Voest

Professor of Medical Oncology, Medical Director of the NKI

Personal details


My work is devoted to two research lines: personalized medicine and understanding resistance to chemotherapy.

My research in the area of personalized medicine consists of large scale genomic sequencing of patients with metastatic cancer, the development of primary cultures of tumors for ex vivo testing (including tumor organoids) and the use of these cultures to improve drug development and to determine which treatment is best for a specific patient.

Resistance to chemotherapy is a major obstacle in successful cancer treatment. We have discovered an intricate signaling network of fatty acids that confers resistance to virtually all genotoxic anti-cancer agents. Understanding the molecular basis of this mechanism is the challenge for the future.

Share this page